This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
by Nataliya Andreychuk, Co-founder and CEO of Viseven Many pharma brands still shy away from marketing directly to patients, depending on conversion through healthcare providers (HCPs). And it is not hard to see why.
The Everest Group PEAK Matrix® is an industry-standard evaluation that ranks service providers on two essential dimensions: market impact and vision & capability. We are deeply honored to be recognized in Everest Group’s PEAK Matrix® for LifeSciences CTMS solutions,” said Dinesh Kashyap, CEO and Founder of Cloudbyz.
In the lifesciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all lifesciences subsidiaries are located in the US. After all, around a third of the world’s leading lifesciences corporations have their headquarters in the country.
The lifesciences history industry has some unique challenges when it comes to compliance. Early lifescience pioneers in foreign markets earned a reputation for lax ethical behaviour, making them a prime target for regulators. No excuses. Get control back.
A successful lifescience webinar engages the audience in a unique manner, drives the right kind of traffic and provides genuine value for attendees. Here are 5 trending lifescience webinar topics that have been resonating well with our audiences. Then view our past lifescience webinars here.
The lifescience industry is dynamic and progressive with 2022 exemplifying significant growth. Agile lifescience companies that were able to adapt to the challenges of the pandemic and ongoing global regulations prospered since the last two years.
The challenge of managing and securing sensitive data, including PHI and PII, is significant for lifesciences organizations. At the same time, the regulatory environment is becoming increasingly complex, with new data protection regulations being introduced regularly.
The lifescience industry is constantly evolving, making it difficult to stay ahead of the curve. Digital transformation is burgeoning and we aim to cover some of the dominant emerging technologies that are currently running the lifescience industry by storm.
Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at Ecolab LifeSciences to find out what the company is planning for the event and how it is navigating current challenges in the industry.
Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at EcoLab LifeSciences to find out what the pharmaceutical manufacturing firm is planning for the event and how it is navigating current challenges in the industry.
If the power of the lifesciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. Building the data-powered lifesciences business .
Xtalks is proud to announce the launch of the Xtalks LifeScience podcast. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. Fresh Conversations About LifeScience Topics. Diverse Voices for Lively Discussions. Sarah is also an experienced webinar moderator.
A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the lifesciences sector amidst recent economic turbulence.
These workspaces mimic their physical counterparts in all ways but are superior in several factors that are leading to explosive growth in this market. Regulations protecting everything are made more robust. The post Virtual data room use for lifesciences M&A deals rising appeared first on Pharmaceutical Technology.
The Pistoia Alliance is a global, not-for-profit alliance that advocates for greater collaboration in lifesciences R&D. It has just announced its four new strategic priorities made up of global pharma and tech representatives to deliver new project ideas to drive industry change.
N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Engagement channels. Joanna Carlish.
From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables lifesciences teams to collaborate efficiently and effectively in 2023. He is responsible for customer engagement, market adoption, and strategic alliances.
The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Sales and Marketing Oversight – April 21, 2021. Darshan Kulkarni and Marc Banjak, General Counsel at Dova Pharmaceuticals, discuss sales compliance in the lifesciences.
If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. While the FDA is responsible for regulating both drugs and devices, they’re handled through completely different processes in different parts of the agency.
A survey by the Pistoia Alliance indicates most professionals believe the tech can accelerate R&D, but companies are stymied by a skills gap and data bias.
A new specialized lab, office and collaboration space for over 100 lifescience and health technology professionals, entrepreneurs, and researchers was recently announced for The Campus, Cherrywood in South Dublin, Ireland.
Many turn to Boston and North Carolinaâs Research Triangle to set up lifescience companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a lifescience and biopharma hub and seems poised for even further growth, in CGT in particular.
With generative AI continuing to create a buzz, OSP took the opportunity to speak to Indegene, a digital-first, lifesciences commercialization company that helps biopharmaceutical, emerging biotech and medical device companies develop products.
But for many lifesciences organisations, these tools are either not yet fully adopted or are not being put to good use within their regulatory functions. The Accenture Technology Vision survey found just one-third of 103 lifesciences executives have high confidence in their data and validate it extensively.
Data is transforming lifesciences, but many organisations are not using its full potential. Lifesciences and the pharmaceutical industry are awash with data. Capturing market share. The combination of health and data, he passionately believes, will transform lifesciences.
As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .
Swoop , a leader in healthcare marketing, recently introduced a groundbreaking portfolio of predictive AI targeting for pharmaceutical and lifesciences advertisers. This capability will usher in a new era in healthcare marketing, moving beyond traditional methods that rely on past data to a future-focused approach.
The latest lifescience competitiveness indicators (LSCIs) were published by the Office of LifeSciences (OLS) in July 2022. The lifesciences ecosystem. The median number of days between marketing authorisation and medicines being made available is included too. Interest in indicators.
The Gen AI revolution promises to redefine various industries, with the lifesciences sector at the forefront of this transformation. OSP had the chance to speak to Tarun Mathur, CEO at Indegene, who was keen to allay many of the fears those in the industry may have.
As a strategic brand consultant at ramarketing, Laura combines her extensive background in clinical research with strategic leadership and creative expression.
Inspired Thinking Group (ITG) the technology-led multichannel marketing activation business, has launched ITG Health to deliver an âautomation-first approachâ to the lifesciences industry.
This prestigious recognition positions Cloudbyz among the top performers in delivering intuitive and scalable EDC solutions to lifesciences organizations worldwide. This prestigious recognition positions Cloudbyz among the top performers in delivering intuitive and scalable EDC solutions to lifesciences organizations worldwide.
In the rapidly evolving landscape of lifesciences, the need for robust, efficient, and compliant pharmacovigilance (PV) solutions has never been greater. In this blog, we’ll explore how these solutions are transforming pharmacovigilance and why they are becoming the go-to choice for forward-thinking lifesciences companies.
Between 2019 and 2021, Alphabet’s venture-capital arms, Google Ventures, and Gradient Ventures, and its private-equity unit, CapitalG, made about 100 deals, a quarter of Alphabet’s combined total, in lifesciences and health care.
In the era of increasing awareness of environmental, social and governance (ESG) policies, lifescience companies are starting to take notice of their benefits. ESG policies can be advantageous for small to mid-sized business-to-business (B2B) lifescience companies in a number of ways. Conclusion.
Lifesciences business Cytiva is set to launch its new platform, designed to accelerate the manufacturing process for autologous CAR-T cell therapies. Find out more about the company's priorities, market challenges, expansion plans and more.
Fujifilm Irvine Scientific, Inc, has announced the acquisition of Shenandoah Biotechnology, a company supplying recombinant proteins to the drug discovery, lifescience research, and cell and gene therapy markets.
It’s time to take what the UK has learnt about the “Holy Trinity” of government, academia, and industry and apply it to creating a “lifesciences superpower”, says health secretary Matt Hancock. It’s about charting a new, better course… and transforming the UK into a lifesciences superpower.
Many lifescience professionals say they are âcautiously positiveâ about the outlook for their industry in 2023, although highlight it wonât be all plain sailing.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content